QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010

Background: Hypertension is considered as a main risk factor for
chronic kidney disease development and progression. Thus, the
control and evaluation of this disease with new software and
devices are especially important in patients who suffer from
chronic kidney disease. Objective: This study aimed to validate the
QardioArm mobile device, which is used for blood pressure (BP)
self-measurement in patients who suffer from chronic kidney
disease, by following the European Society of Hypertension
International Protocol 2 (ESH-IP2) guidelines. Methods: A
validation study was carried out by following the ESH-IP2
guidelines. A sample of 33 patients with chronic kidney disease
self-measured their BP by using the QardioArm and Omron M3
Intellisense devices. Heart rate (HR), diastolic BP, and systolic
BP were measured. Results: The QardioArm fulfilled the ESH-IP2
validation criteria in patients who suffered from chronic kidney
disease. Conclusions: Thus, this study is considered as the first
validation using a wireless upper arm oscillometric device
connected to an app to measure BP and HR meeting the ESH-IP2
requirements in patients who suffer from chronic kidney disease.
New validation studies following the ESH-IP2 guidelines should be
carried out using different BP devices in patients with specific
diseases.

This is the abstract only. Read the full article on the JMIR site.
JMIR is the leading open access journal for eHealth and healthcare
in the Internet age.
Source: All – Medical Journals
QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010